Therapeutic Opportunities in Progressive Stages of Spinal Cord Injury

The summary for the Therapeutic Opportunities in Progressive Stages of Spinal Cord Injury grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Therapeutic Opportunities in Progressive Stages of Spinal Cord Injury: The National Institute of Neurological Disorders and Stroke (NINDS) invites applications for basic studies that define therapeutic opportunities during the progressive stages of spinal cord injury (SCI) from acute through chronic time points. Although numerous neuroprotective and repair strategies have been identified that improve anatomical or functional outcome after SCI in animal models, the causal relationship between cellular or anatomical findings and functional outcomes has not been established. This RFA seeks research to 1) elucidate the mechanisms that underlie recovery induced by neuroprotection or repair strategies in animal models, 2) define progressive changes in acute, subacute or chronic stages after SCI that influence cell survival, regeneration, sprouting and/or recovery of function, 3) target therapeutic strategies in animal models to clinically-relevant stages and types of SCI, based on known pathophysiological processes, anatomical or functional/clinical outcomes.

Federal Grant Title:	Therapeutic Opportunities in Progressive Stages of Spinal Cord Injury
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-NS-04-004
Type of Funding:	Grant
CFDA Numbers:	93.853
CFDA Descriptions:	Extramural Research Programs in the Neurosciences and Neurological Disorders
Current Application Deadline:	No deadline provided
Original Application Deadline:	Dec 23, 2003
Posted Date:	Aug 15, 2003
Creation Date:	Jan 22, 2004
Archive Date:	Jan 22, 2004
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants: • Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) Region Ge...; • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...; • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...; • Mechanistic and Hemodynamic Basis of Diffuse White Matter Disease in Vascular Contribution...; • Tools and resources to understand the vascular pathophysiology of in vivo neuroimaging fin...; • NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44); • NINDS Institutional Center Core Grants to Support Neuroscience Research; • Career Development Award to Promote Diversity in Neuroscience Research
More Grants from the National Institutes of Health: • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...; • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...; • Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional); • Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial No...; • Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimenta...